ReviewBlood and lymphatic cancer : targets and therapy2022
FLT3 Inhibitors as Maintenance Therapy after Allogeneic Stem-Cell Transplantation.
Amanda Blackmon et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
8 papers cite it
this papercites it